Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic

Completed · Not applicable

Conditions studied: Anxiety, Chronic Pain, Opioid Use, Unspecified

In brief

The purpose of this study is to characterize and improve controlled substance, carisoprodol and tramadol use in an internal medicine residents' clinic. Specific objectives of this study include: * To measure the adherence to a controlled substance treatment agreement (CSTA) before and after implementation of a population management intervention * To determine the number of patients on a CSTA with a discrepancy identified on a urine drug screen or an Ohio Automated Rx Reporting System (OARRS) report * To track the number of patients on a morphine equivalent dose (MED) of ≥ 80 mg/day before and after implementation of a review intervention * To characterize the healthcare utilization of patients taking controlled substances, carisoprodol, or tramadol by tracking the mean number of ED visits, hospital admissions, telephone calls, and clinic office visits during a 6 month period

Key facts

Study ID

NCT02244099

Run by

Ohio State University

People needed

96

Starts

2014-09-01

Expected to finish

2015-03-01

Last updated by the study team

2015-09-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 18 years and older
• Residents and attending physicians who work in the resident continuity practice

You may not qualify if…

• Age < 18 years of age

Where it is running

• The Ohio State University — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.